CoreAge Rx

The product pages give a starting point, not the whole purchase

The current semaglutide product page starts at $79 a month and the tirzepatide page at $129. The homepage repeats those figures beside same-price-at-every-dose advertising, included supplies and free shipping. Product pages also say there is no membership fee or long-term contract. Those are useful reasons to compare CoreAge with another self-pay service.

The figures are not consistent everywhere. Site navigation still promotes semaglutide from $99, and a separate campaign advertises a flat $129 while its footer qualifies starting prices as based on twelve months paid in full. That campaign condition does not establish the terms of the separate product-page offers. We would ask which offer applies to the exact prescription before choosing. A starting figure should not be treated as a confirmed charge, a particular vial quantity or a promise that every preparation has identical terms.

Flat dose pricing still needs a prescription-specific quote

The FAQ says higher doses do not cost more and that a price selected at purchase stays the same in later months. That is an advertised pricing policy, not evidence that your prescription has already been approved or that the same offer applies across different routes and formulations. Confirm the initial amount, recurring amount and medication quantity together.

The FAQ describes tirzepatide as typically formulated with B12, while saying a different formulation can be discussed with the prescriber when medically appropriate. That does not guarantee an available alternative or establish an added clinical benefit from B12. Request the actual ingredient label, concentration and usable prescribed supply rather than choosing from the brand name alone.

Resolve when payment happens and whether it renews

The FAQ says there are no automatic rebills, but the refund policy permits both one-time purchases and automatically renewing subscriptions. Its cancellation instructions require notice before the applicable renewal is processed. We would not assume that a general no-rebill answer settles the plan being purchased.

Timing is also inconsistent: one FAQ answer explains charging before physician review, while another says medication is charged when shipped. The refund policy describes placing the order before completing required intake and review steps. Get the actual charge date, renewal setting and treatment period in writing; a monthly headline does not answer those questions.

The rejection-refund promise has an important exception

The FAQ promises an automatic full refund when a provider does not approve the prescription. The refund policy instead says the refundable treatment or medication portion is returned while an applicable $50–$100 consultation fee remains nonrefundable after review begins. Those are materially different promises. Ask which fee applies and what amount would be returned before authorizing payment.

Before provider approval and pharmacy transmission, cancellation may still be requested if the order has not otherwise become nonrefundable. Once both approval and pharmacy transmission have occurred, prescription sales are final even before shipment. Canceling a future subscription does not itself refund a processed order or restore the value of medication already committed to fulfillment.

The Terms of Use also say refunds are generally unavailable after clinical review is completed and/or the prescription is transmitted, with exceptions described in the refund policy. That wording can point to an earlier review stage than the refund policy’s approval-and-transmission statement. Ask which cutoff applies if you cancel between those stages; we cannot establish legal priority between the documents.

A health-related stop can leave prepaid value as credit

The policy now says that if a clinician advises stopping medication because of health concerns, adverse reactions or an underlying condition, unused portions of prepaid multi-month treatment are not refundable in cash. Any eligible remaining balance becomes store credit. It says that credit may be transferred to another patient, subject to medical approval, or used for nonprescription products and future eligible services or products. That is a different outcome from getting your money back; ask how an eligible balance would be calculated before prepaying.

The documentation deadline matters even before shipment

The refund policy makes an order nonrefundable after thirty calendar days from purchase, including when missing identification, lab results or other requested information prevents completion, except where applicable law requires otherwise. That cutoff can therefore matter before approval, compounding or shipment. We would complete requested paperwork promptly and contact support early if the process stalls.

Its shipping estimates also distinguish the stages: orders are typically completed in about five to seven business days when required information is provided promptly, and medication usually arrives about two to three business days after dispatch. These are estimates, not a guaranteed delivery date. Ask about the whole interval to usable medication rather than treating carrier transit as the entire wait. Its policy denies refunds or returns for carrier or other external transit delays after the pharmacy dispenses or dispatches medication. Lost or damaged shipments are separately reviewed for possible replacement or reshipment.

A named medical group is useful, but not your care assignment

The site distinguishes the technology operator, DSO Fine Shrimp doing business as CoreAgeRx, from the medical professional entities named in its footer, including MDI Medical Group P.C. and MD Integrations-related entities. Its FAQ describes physician review, with video or live chat needed in some states. That is a care model to understand, not a promise of an immediate prescription.

The FAQ lists physicians for some states, but we have not independently reverified those individual licenses or established a patient assignment. Ask who will prescribe, how to reach that team about treatment questions and what follow-up is included. The refund policy may require labs or records without stating a complete testing package or lab cost. A low advertised medication price does not settle the cost of those requirements.

Confirm the pharmacy and treatment-specific state access

The FAQ says service is US-only and that restrictions depend on the therapy and medication. That is narrower than an unconditional promise of every product in all fifty states. Confirm your address and actual prescription before transferring care or depending on a refill. General marketing coverage is not a pharmacy or clinician license check.

The pharmacy answer refers to partner facilities selected for the therapy and asks readers to contact support for the actual pharmacy. No assigned dispenser or physical compounder is established by that answer. Obtain the facility name, location and contact details, then check the relevant board record. We would resolve that question before paying if a particular pharmacy or preparation matters to the decision.

Our recommendation depends on the written purchase terms

CoreAge has an understandable appeal for someone comparing self-pay prices across prescribed doses. The updated product-page figures are worth comparing, but the difference between marketing pages and the payment/refund policy deserves equal attention. We would choose it only after obtaining one clear initial-and-renewal quote, usable supply, care assignment and applicable refund rule.

If an unconditional rejection refund or a settled no-renewal arrangement is essential, ask for the selected written terms before proceeding and compare another service if the answer remains inconsistent. We have not enrolled, tested the support team or received medication. This recommendation concerns the public offer and its contract questions, not a personal treatment result.